Yuanhua Wireless Capsule Endoscopy System

The Yuanhua Wireless Capsule Endoscopy System offers both active robotic-controlled and passive peristalsis-driven options for full gastrointestinal tract examination. Developed by Milvus Technologies, a wholly-owned subsidiary of Yuanhua Tech, this platform integrates proprietary AI diagnostic software for automated image analysis.

Product Overview

Traditional gastrointestinal endoscopy requires sedation and causes patient discomfort, limiting its suitability for routine screening. Capsule endoscopy addresses these limitations by enabling patients to swallow a small camera device that captures images throughout the digestive tract.

Yuanhua Tech’s system distinguishes itself through two operational modes: an active system with robotic control and sensor technologies enabling automatic navigation, and a passive system that relies on natural gastrointestinal peristalsis. Both variants transmit real-time high-definition images to external receivers for physician review and AI-assisted analysis.

The platform targets the growing demand for non-invasive diagnostic alternatives in gastroenterology, particularly for patients who cannot tolerate conventional endoscopy or require frequent surveillance.

Key Features

Dual Operation Modes: Active capsule system provides controlled navigation using proprietary robotic and sensor technologies, while passive system offers simpler deployment leveraging natural GI tract movement.

Real-Time HD Imaging: Advanced optical and electronic technologies enable transmission of high-definition images throughout the examination, providing thorough visualization of the entire digestive tract.

AI-Assisted Diagnostics: Proprietary software developed by Yuanhua Tech automatically analyzes captured images, flagging potential abnormalities and assisting physicians in diagnostic interpretation.

Non-Invasive Examination: Eliminates the need for sedation, insufflation, or scope insertion, improving patient comfort and enabling outpatient procedures.

Technical Specifications

Designed for non-invasive gastrointestinal examination, Yuanhua’s capsule system offers both robotic-controlled active navigation and passive peristalsis modes with AI-assisted image analysis for the full digestive tract.

Clinical Applications

The wireless capsule endoscopy system is designed for examination, diagnosis, and treatment planning across the gastrointestinal tract:

Small Bowel Evaluation: Visualization of areas inaccessible to conventional upper and lower endoscopy, including detection of obscure GI bleeding sources, Crohn’s disease assessment, and small bowel tumor screening.

Esophageal and Gastric Screening: Non-invasive alternative for patients requiring surveillance of Barrett’s esophagus, gastric polyps, or other upper GI conditions.

Colorectal Assessment: Complementary tool for patients with incomplete colonoscopy or those at average risk seeking less invasive screening options.

The AI diagnostic component aims to reduce physician workload by pre-screening thousands of captured images and highlighting frames requiring detailed review.

Regulatory Status

The wireless capsule endoscopy system is currently in the research and development phase. According to company disclosures, Yuanhua Tech has completed development of digestive tract products and is preparing for preclinical research followed by clinical verification.

Frequently Asked Questions

Is the Yuanhua capsule endoscope currently available?

The wireless capsule endoscopy system is in the development pipeline. Yuanhua Tech has indicated that the product has completed development and will enter preclinical research and clinical verification stages.

What is the difference between active and passive capsule systems?

The active system uses robotic control and sensor technologies for automated navigation through the GI tract, while the passive system travels via natural peristaltic movement. Both transmit real-time images for AI-assisted diagnosis.

Does Yuanhua Tech offer other endoscopic products?

Yes, the company is also developing natural orifice transluminal endoscopic surgery (NOTES) robots and intelligent puncture/intervention systems through its Milvus Technologies subsidiary.